Inaktiver Wert

Andere Sprachen LabStyle Innovations Corp OTC Bulletin Board

Aktien

DRIO

US50544T2033

DRIO

Schlusskurs OTC Bulletin Board Andere Börsenplätze
- ^USD	-

14:30	Transcript : DarioHealth Corp., Q1 2024 Earnings Call, May 15, 2024
25.04.	DarioHealth Corp. veröffentlicht neue, von Fachleuten begutachtete Studie, die den Beweis erbringt, dass die Verwaltung kardiometabolischer Erkrankungen auf einer integrierten Plattform die klinischen Ergebnisse verbessert	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Earnings Flash (DRIO) DARIOHEALTH Reports Q1 Revenue $5.8M, vs. Street Est of $6.8M	12:42
DarioHealth Reports First Quarter 2024 Financial and Operating Results	12:31
DarioHealth to Report First Quarter 2024 Results on Wednesday, May 15th	07.05.
Dario Publishes New Peer-Reviewed Study that Deepens the Body of Evidence that Managing Cardiometabolic Conditions in One Integrated Platform Improves Clinical Outcomes	25.04.
DarioHealth Corp. Publishes New Peer-Reviewed Study That Deepens the Body of Evidence That Managing Cardiometabolic Conditions in One Integrated Platform Improves Clinical Outcomes	25.04.
Dario Signs Two Employers for Cardiometabolic Suite with Integrated GLP-1 Solution	18.04.
DarioHealth Corp. Signs Two Employers for Cardiometabolic Suite with Integrated Glp-1 Solution	18.04.
Dario Publishes Two New Peer-Reviewed Studies Demonstrating Impact of Digital Behavioral Health	10.04.
DarioHealth Corp. Publishes Two New Peer-Reviewed Studies Demonstrating Impact of Digital Behavioral Health	10.04.
TWO NATIONAL EMPLOYERS SELECT DARIO S INTEGRATED CHRONIC CONDITION SOLUTION TO IMPROVE EMPLOYEE HEALTH	03.04.
Two National Employers Select Dario's Integrated Chronic Condition Solution to Improve Employee Health	02.04.
Two National Employers Select DarioHealth Corp.'S Integrated Chronic Condition Solution to Improve Employee Health	02.04.
DarioHealth : Q4 and full year 2023 earnings call transcript	01.04.
DarioHealth Reports Fourth Quarter and Full-Year 2023 Financial and Operating Results	28.03.
DarioHealth Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	28.03.
North American Morning Briefing : Stocks Set for -2-	28.03.
DARIOHEALTH TO REPORT FOURTH QUARTER 2023 RESULTS ON THURSDAY, MARCH 28TH	21.03.
North American Morning Briefing : Investors -2-	21.03.
New Research from Dario Demonstrates Ability to Deliver Improved Health Outcomes with Integrated Solution for Members Managing Weight and Blood Glucose with or without GLP-1 Medications	12.03.
DarioHealth Corp. Announces Two New Clinical Studies Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes 2024	12.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen LabStyle Innovations Corp OTC Bulletin Board

Aktien

DRIO

US50544T2033

DRIO

Andere Sprachen

Filter